Comparative Characterization and Risk Stratification of Asymptomatic and Presymptomatic Patients With COVID-19
Lei Shi,Rong Ding,Tingting Zhang,Wei Wu,Ziyu Wang,Xiuzhi Jia,Kening Li,Yuan Liang,Jie Li,Mengyan Zhu,Bin Huang,Lingxiang Wu,Min Wu,Jing Chen,Chaochen Wang,Bin Huang,Caidong Liu,Hongbing Shen,Qianghu Wang,Xinyi Xia,Pengping Li,Sali Lyu,Ying Xiao
DOI: https://doi.org/10.3389/fimmu.2021.700449
IF: 7.3
2021-07-09
Frontiers in Immunology
Abstract:The identification of asymptomatic, non-severe presymptomatic, and severe presymptomatic coronavirus disease 2019 (COVID-19) in patients may help optimize risk-stratified clinical management and improve prognosis. This single-center case series from Wuhan Huoshenshan Hospital, China, included 2,980 patients with COVID-19 who were hospitalized between February 4, 2020 and April 10, 2020. Patients were diagnosed as asymptomatic (n = 39), presymptomatic (n = 34), and symptomatic (n = 2,907) upon admission. This study provided an overview of asymptomatic, presymptomatic, and symptomatic COVID-19 patients, including detection, demographics, clinical characteristics, and outcomes. Upon admission, there was no significant difference in clinical symptoms and CT image between asymptomatic and presymptomatic patients for diagnosis reference. The mean area under the receiver operating characteristic curve (AUC) of the differential diagnosis model to discriminate presymptomatic patients from asymptomatic patients was 0.89 (95% CI, 0.81-0.98). Importantly, the severe and non-severe presymptomatic patients can be further stratified (AUC = 0.82). In conclusion, the two-step risk-stratification model based on 10 laboratory indicators can distinguish among asymptomatic, severe presymptomatic, and non-severe presymptomatic COVID-19 patients on admission. Moreover, single-cell data analyses revealed that the CD8+T cell exhaustion correlated to the progression of COVID-19.
immunology